Vestal Point Capital, LP Dianthus Therapeutics Inc Transaction History

Vestal Point Capital, LP

1,180,000

Previous 3,200,000 63.13%

$46.4 Billion

Previous $59.6 Billion 22.11%

2.1%

Previous 3.14%

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	N/A	-2,020,000 Reduced 63.13%	1,180,000 $46.4 Billion
Q2 2025 Aug 14, 2025	BUY	N/A	1,499,931 Added 88.23%	3,200,000 $59.6 Billion
Q1 2025 May 15, 2025	BUY	N/A	625,069 Added 58.15%	1,700,069 $30.8 Billion
Q4 2024 Feb 14, 2025	BUY	N/A	680,000 Added 172.15%	1,075,000 $23.4 Billion
Q3 2024 Nov 14, 2024	SELL	N/A	-205,000 Reduced 34.17%	395,000 $10.8 Billion

Q2 2024 Aug 14, 2024	BUY	N/A	145,000 Added 31.87%	600,000 $15.5 Billion
Q1 2024 May 13, 2024	BUY	N/A	320,000 Added 237.04%	455,000 $13.7 Billion
Q4 2023 Feb 13, 2024	BUY	N/A	135,000 New	135,000 $1.4 Billion

Get notified when there are updates to the investment portfolio of Vestal Point Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Vestal Point Capital, LP with notifications on news.